Industry: Chemical & Material
Published Date: 2026-04-18
Pages: 139 Pages
Report ld: 6502354
Request Sample
Customized Report
The global Sofosbuvir API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sofosbuvir API competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sofosbuvir(CAS:1190307-88-0) is a medication used to treat hepatitis C.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report delivers a comprehensive overview of the global Sofosbuvir API market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sofosbuvir API. The Sofosbuvir API market size, estimates, and forecasts are provided in terms of output/shipments (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sofosbuvir API market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sofosbuvir API manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Sofosbuvir API manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Sofosbuvir API production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Sofosbuvir API consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Sofosbuvir API Market Overview
1.1 Product Definition
1.2 Sofosbuvir API by Type
1.2.1 Global Sofosbuvir API Market Value Growth Rate Analysis by Type: 2025 vs 2032
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Sofosbuvir API by Application
1.3.1 Global Sofosbuvir API Market Value Growth Rate Analysis by Application: 2025 vs 2032
1.3.2 Tablets
1.3.3 Others
1.4 Global Market Growth Prospects
1.4.1 Global Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
1.4.2 Global Sofosbuvir API Production Capacity Estimates and Forecasts (2021–2032)
1.4.3 Global Sofosbuvir API Production Estimates and Forecasts (2021–2032)
1.4.4 Global Sofosbuvir API Market Average Price Estimates and Forecasts (2021–2032)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Sofosbuvir API Production Market Share by Manufacturers (2021–2026)
2.2 Global Sofosbuvir API Production Value Market Share by Manufacturers (2021–2026)
2.3 Global Key Players of Sofosbuvir API, Industry Ranking, 2024 vs 2025
2.4 Global Sofosbuvir API Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.5 Global Sofosbuvir API Average Price by Manufacturers (2021–2026)
2.6 Global Key Manufacturers of Sofosbuvir API, Manufacturing Footprints and Headquarters
2.7 Global Key Manufacturers of Sofosbuvir API, Product Offerings and Applications
2.8 Global Key Manufacturers of Sofosbuvir API, Date of Entry into the Industry
2.9 Sofosbuvir API Market Competitive Situation and Trends
2.9.1 Sofosbuvir API Market Concentration Rate
2.9.2 Top 5 and Top 10 Global Sofosbuvir API Players Market Share by Revenue
2.10 Mergers & Acquisitions and Expansion
3 Sofosbuvir API Production by Region
3.1 Global Sofosbuvir API Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.2 Global Sofosbuvir API Production Value by Region (2021–2032)
3.2.1 Global Sofosbuvir API Production Value by Region (2021–2026)
3.2.2 Global Forecasted Production Value of Sofosbuvir API by Region (2027–2032)
3.3 Global Sofosbuvir API Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
3.4 Global Sofosbuvir API Production Volume by Region (2021–2032)
3.4.1 Global Sofosbuvir API Production by Region (2021–2026)
3.4.2 Global Forecasted Production of Sofosbuvir API by Region (2027–2032)
3.5 Global Sofosbuvir API Market Price Analysis by Region (2021–2032)
3.6 Global Sofosbuvir API Production, Value, and Year-over-Year Growth
3.6.1 North America Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
3.6.2 Europe Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
3.6.3 China Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
3.6.4 India Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
3.6.5 Mid East & Africa Sofosbuvir API Production Value Estimates and Forecasts (2021–2032)
4 Sofosbuvir API Consumption by Region
4.1 Global Sofosbuvir API Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032
4.2 Global Sofosbuvir API Consumption by Region (2021–2032)
4.2.1 Global Sofosbuvir API Consumption by Region (2021–2026)
4.2.2 Global Sofosbuvir API Forecasted Consumption by Region (2027–2032)
4.3 North America
4.3.1 North America Sofosbuvir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.3.2 North America Sofosbuvir API Consumption by Country (2021–2032)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Sofosbuvir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.4.2 Europe Sofosbuvir API Consumption by Country (2021–2032)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Sofosbuvir API Consumption Growth Rate by Region: 2021 vs 2025 vs 2032
4.5.2 Asia Pacific Sofosbuvir API Consumption by Region (2021–2032)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Sofosbuvir API Consumption Growth Rate by Country: 2021 vs 2025 vs 2032
4.6.2 Latin America, Middle East & Africa Sofosbuvir API Consumption by Country (2021–2032)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Sofosbuvir API Production by Type (2021–2032)
5.1.1 Global Sofosbuvir API Production by Type (2021–2026)
5.1.2 Global Sofosbuvir API Production by Type (2027–2032)
5.1.3 Global Sofosbuvir API Production Market Share by Type (2021–2032)
5.2 Global Sofosbuvir API Production Value by Type (2021–2032)
5.2.1 Global Sofosbuvir API Production Value by Type (2021–2026)
5.2.2 Global Sofosbuvir API Production Value by Type (2027–2032)
5.2.3 Global Sofosbuvir API Production Value Market Share by Type (2021–2032)
5.3 Global Sofosbuvir API Price by Type (2021–2032)
6 Segment by Application
6.1 Global Sofosbuvir API Production by Application (2021–2032)
6.1.1 Global Sofosbuvir API Production by Application (2021–2026)
6.1.2 Global Sofosbuvir API Production by Application (2027–2032)
6.1.3 Global Sofosbuvir API Production Market Share by Application (2021–2032)
6.2 Global Sofosbuvir API Production Value by Application (2021–2032)
6.2.1 Global Sofosbuvir API Production Value by Application (2021–2026)
6.2.2 Global Sofosbuvir API Production Value by Application (2027–2032)
6.2.3 Global Sofosbuvir API Production Value Market Share by Application (2021–2032)
6.3 Global Sofosbuvir API Price by Application (2021–2032)
7 Key Companies Profiled
7.1 Mylan
7.1.1 Mylan Sofosbuvir API Company Information
7.1.2 Mylan Sofosbuvir API Product Portfolio
7.1.3 Mylan Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.1.4 Mylan Main Business and Markets Served
7.1.5 Mylan Recent Developments/Updates
7.2 Teva
7.2.1 Teva Sofosbuvir API Company Information
7.2.2 Teva Sofosbuvir API Product Portfolio
7.2.3 Teva Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.2.4 Teva Main Business and Markets Served
7.2.5 Teva Recent Developments/Updates
7.3 Century Pharmaceuticals
7.3.1 Century Pharmaceuticals Sofosbuvir API Company Information
7.3.2 Century Pharmaceuticals Sofosbuvir API Product Portfolio
7.3.3 Century Pharmaceuticals Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.3.4 Century Pharmaceuticals Main Business and Markets Served
7.3.5 Century Pharmaceuticals Recent Developments/Updates
7.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd
7.4.1 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Company Information
7.4.2 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Product Portfolio
7.4.3 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.4.4 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Main Business and Markets Served
7.4.5 Beijing Huikang Boyuan Chemical Tech Co.,Ltd Recent Developments/Updates
7.5 Fuxin Long Rui Pharmaceutical
7.5.1 Fuxin Long Rui Pharmaceutical Sofosbuvir API Company Information
7.5.2 Fuxin Long Rui Pharmaceutical Sofosbuvir API Product Portfolio
7.5.3 Fuxin Long Rui Pharmaceutical Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.5.4 Fuxin Long Rui Pharmaceutical Main Business and Markets Served
7.5.5 Fuxin Long Rui Pharmaceutical Recent Developments/Updates
7.6 Alembic Pharmaceuticals Limited
7.6.1 Alembic Pharmaceuticals Limited Sofosbuvir API Company Information
7.6.2 Alembic Pharmaceuticals Limited Sofosbuvir API Product Portfolio
7.6.3 Alembic Pharmaceuticals Limited Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.6.4 Alembic Pharmaceuticals Limited Main Business and Markets Served
7.6.5 Alembic Pharmaceuticals Limited Recent Developments/Updates
7.7 Hetero Drugs
7.7.1 Hetero Drugs Sofosbuvir API Company Information
7.7.2 Hetero Drugs Sofosbuvir API Product Portfolio
7.7.3 Hetero Drugs Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.7.4 Hetero Drugs Main Business and Markets Served
7.7.5 Hetero Drugs Recent Developments/Updates
7.8 Jiangsu Yutian Pharmaceutical
7.8.1 Jiangsu Yutian Pharmaceutical Sofosbuvir API Company Information
7.8.2 Jiangsu Yutian Pharmaceutical Sofosbuvir API Product Portfolio
7.8.3 Jiangsu Yutian Pharmaceutical Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.8.4 Jiangsu Yutian Pharmaceutical Main Business and Markets Served
7.8.5 Jiangsu Yutian Pharmaceutical Recent Developments/Updates
7.9 Aspire Lifesciences Pvt Ltd
7.9.1 Aspire Lifesciences Pvt Ltd Sofosbuvir API Company Information
7.9.2 Aspire Lifesciences Pvt Ltd Sofosbuvir API Product Portfolio
7.9.3 Aspire Lifesciences Pvt Ltd Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.9.4 Aspire Lifesciences Pvt Ltd Main Business and Markets Served
7.9.5 Aspire Lifesciences Pvt Ltd Recent Developments/Updates
7.10 Haoyuan Chemexpress Co.Ltd
7.10.1 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Company Information
7.10.2 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Product Portfolio
7.10.3 Haoyuan Chemexpress Co.Ltd Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.10.4 Haoyuan Chemexpress Co.Ltd Main Business and Markets Served
7.10.5 Haoyuan Chemexpress Co.Ltd Recent Developments/Updates
7.11 CHEMO
7.11.1 CHEMO Sofosbuvir API Company Information
7.11.2 CHEMO Sofosbuvir API Product Portfolio
7.11.3 CHEMO Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.11.4 CHEMO Main Business and Markets Served
7.11.5 CHEMO Recent Developments/Updates
7.12 Hanways Chempharm Co., Limited
7.12.1 Hanways Chempharm Co., Limited Sofosbuvir API Company Information
7.12.2 Hanways Chempharm Co., Limited Sofosbuvir API Product Portfolio
7.12.3 Hanways Chempharm Co., Limited Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.12.4 Hanways Chempharm Co., Limited Main Business and Markets Served
7.12.5 Hanways Chempharm Co., Limited Recent Developments/Updates
7.13 Guangzhou Tosun Pharmaceutical
7.13.1 Guangzhou Tosun Pharmaceutical Sofosbuvir API Company Information
7.13.2 Guangzhou Tosun Pharmaceutical Sofosbuvir API Product Portfolio
7.13.3 Guangzhou Tosun Pharmaceutical Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.13.4 Guangzhou Tosun Pharmaceutical Main Business and Markets Served
7.13.5 Guangzhou Tosun Pharmaceutical Recent Developments/Updates
7.14 CAD Middle East Pharmaceutical Industries LLC
7.14.1 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Company Information
7.14.2 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Product Portfolio
7.14.3 CAD Middle East Pharmaceutical Industries LLC Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.14.4 CAD Middle East Pharmaceutical Industries LLC Main Business and Markets Served
7.14.5 CAD Middle East Pharmaceutical Industries LLC Recent Developments/Updates
7.15 Srini Pharmaceuticals
7.15.1 Srini Pharmaceuticals Sofosbuvir API Company Information
7.15.2 Srini Pharmaceuticals Sofosbuvir API Product Portfolio
7.15.3 Srini Pharmaceuticals Sofosbuvir API Production, Value, Price, and Gross Margin (2021–2026)
7.15.4 Srini Pharmaceuticals Main Business and Markets Served
7.15.5 Srini Pharmaceuticals Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Sofosbuvir API Industry Chain Analysis
8.2 Sofosbuvir API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Sofosbuvir API Production Modes and Processes
8.4 Sofosbuvir API Sales and Marketing
8.4.1 Sofosbuvir API Sales Channels
8.4.2 Sofosbuvir API Distributors
8.5 Sofosbuvir API Customer Analysis
9 Sofosbuvir API Market Dynamics
9.1 Sofosbuvir API Industry Trends
9.2 Sofosbuvir API Market Drivers
9.3 Sofosbuvir API Market Challenges
9.4 Sofosbuvir API Market Restraints
9.5 Impact of U.S. Tariffs
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Sofosbuvir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 139
USD 3950.00
(Single User License)
The global Sofosbuvir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-09
Pages: 99
USD 4250.00
(Single User License)
The global Sofosbuvir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-09
Pages: 151
USD 4900.00
(Single User License)
The global market for Sofosbuvir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 125
USD 3950.00
(Single User License)
The global market for Sofosbuvir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-16
Pages: 96
USD 2900.00
(Single User License)
Sofosbuvir(CAS:1190307-88-0) is a medication used to treat hepatitis C.
Published Date: 2024-02-07
Pages: 121
USD 2900.00
(Single User License)
The global market for Sofosbuvir API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 139
The global Sofosbuvir API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-09
Pages: 99
The global Sofosbuvir API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-09
Pages: 151
The global market for Sofosbuvir API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 125
The global market for Sofosbuvir API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-16
Pages: 96
Sofosbuvir(CAS:1190307-88-0) is a medication used to treat hepatitis C.
Published: 2024-02-07
Pages: 121
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now